This patent covers the use of GLP-2 for stimulation of stem cells in the upper GI tract. This patent is useful for treatment of pathologies associated with malfunction of these cells, such as mucositis, gastritis, or various types of injuries.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.